Lymphoma Clinical Trials
As one of the nation’s leading academic medical centers, UT Southwestern Medical Center takes part in a variety of clinical trials aimed at improving the outcomes of patients with different types of lymphoma.
Current lymphoma trials at UT Southwestern include:
- Clinical Study Assessing Outcomes, Adverse Events, Treatment Patterns, and Quality of Life in Patients Diagnosed With Mycosis Fungoides Cutaneous T-cell Lymphoma
- NCI-MATCH: Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma
- Phase I Trial of IV Fenretinide (4-HPR) Plus IV Safingol for Patients With Relapsed Malignancies
- M9177: Phase II Study of Dose-Adjusted EPOCH+/- Rituximab in Adults with Untreated Burkitt Lymphoma, C-Myc Positive Diffuse Large B-Cell Lymphoma and Plasmablastic Lymphoma
Patients should speak
with their doctor about opportunities to participate in a clinical trial.